DYNE THERAPEUTICS Trademark

Trademark Overview


On Thursday, February 8, 2024, a trademark application was filed for DYNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DYNE THERAPEUTICS trademark a serial number of 98397757. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Dyne Therapeutics, Inc.. The DYNE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders

Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders

General Information


Serial Number98397757
Word MarkDYNE THERAPEUTICS
Filing DateThursday, February 8, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDyne Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameDyne Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Thursday, February 8, 2024NEW APPLICATION ENTERED
Friday, June 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 2, 2024ASSIGNED TO EXAMINER
Thursday, September 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT